183 related articles for article (PubMed ID: 16235699)
1. Clinical experience using incubated autologous macrophages as a treatment for complete spinal cord injury: phase I study results.
Knoller N; Auerbach G; Fulga V; Zelig G; Attias J; Bakimer R; Marder JB; Yoles E; Belkin M; Schwartz M; Hadani M
J Neurosurg Spine; 2005 Sep; 3(3):173-81. PubMed ID: 16235699
[TBL] [Abstract][Full Text] [Related]
2. Autologous incubated macrophage therapy in acute, complete spinal cord injury: results of the phase 2 randomized controlled multicenter trial.
Lammertse DP; Jones LA; Charlifue SB; Kirshblum SC; Apple DF; Ragnarsson KT; Falci SP; Heary RF; Choudhri TF; Jenkins AL; Betz RR; Poonian D; Cuthbert JP; Jha A; Snyder DA; Knoller N
Spinal Cord; 2012 Sep; 50(9):661-71. PubMed ID: 22525310
[TBL] [Abstract][Full Text] [Related]
3. Oscillating field stimulation for complete spinal cord injury in humans: a phase 1 trial.
Shapiro S; Borgens R; Pascuzzi R; Roos K; Groff M; Purvines S; Rodgers RB; Hagy S; Nelson P
J Neurosurg Spine; 2005 Jan; 2(1):3-10. PubMed ID: 15658119
[TBL] [Abstract][Full Text] [Related]
4. Safety and neurological assessments after autologous transplantation of bone marrow mesenchymal stem cells in subjects with chronic spinal cord injury.
Mendonça MV; Larocca TF; de Freitas Souza BS; Villarreal CF; Silva LF; Matos AC; Novaes MA; Bahia CM; de Oliveira Melo Martinez AC; Kaneto CM; Furtado SB; Sampaio GP; Soares MB; dos Santos RR
Stem Cell Res Ther; 2014 Nov; 5(6):126. PubMed ID: 25406723
[TBL] [Abstract][Full Text] [Related]
5. Activated autologous macrophage implantation in a large-animal model of spinal cord injury.
Assina R; Sankar T; Theodore N; Javedan SP; Gibson AR; Horn KM; Berens M; Sonntag VK; Preul MC
Neurosurg Focus; 2008; 25(5):E3. PubMed ID: 18980477
[TBL] [Abstract][Full Text] [Related]
6. Autologous bone marrow-derived cell therapy combined with physical therapy induces functional improvement in chronic spinal cord injury patients.
El-Kheir WA; Gabr H; Awad MR; Ghannam O; Barakat Y; Farghali HA; El Maadawi ZM; Ewes I; Sabaawy HE
Cell Transplant; 2014 Apr; 23(6):729-45. PubMed ID: 23452836
[TBL] [Abstract][Full Text] [Related]
7. Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: Phase I/II clinical trial.
Yoon SH; Shim YS; Park YH; Chung JK; Nam JH; Kim MO; Park HC; Park SR; Min BH; Kim EY; Choi BH; Park H; Ha Y
Stem Cells; 2007 Aug; 25(8):2066-73. PubMed ID: 17464087
[TBL] [Abstract][Full Text] [Related]
8. Safety and possible outcome assessment of autologous Schwann cell and bone marrow mesenchymal stromal cell co-transplantation for treatment of patients with chronic spinal cord injury.
Yazdani SO; Hafizi M; Zali AR; Atashi A; Ashrafi F; Seddighi AS; Soleimani M
Cytotherapy; 2013 Jul; 15(7):782-91. PubMed ID: 23731761
[TBL] [Abstract][Full Text] [Related]
9. Transplantation of autologous olfactory ensheathing cells in complete human spinal cord injury.
Tabakow P; Jarmundowicz W; Czapiga B; Fortuna W; Miedzybrodzki R; Czyz M; Huber J; Szarek D; Okurowski S; Szewczyk P; Gorski A; Raisman G
Cell Transplant; 2013; 22(9):1591-612. PubMed ID: 24007776
[TBL] [Abstract][Full Text] [Related]
10. Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study.
Pal R; Venkataramana NK; Bansal A; Balaraju S; Jan M; Chandra R; Dixit A; Rauthan A; Murgod U; Totey S
Cytotherapy; 2009; 11(7):897-911. PubMed ID: 19903102
[TBL] [Abstract][Full Text] [Related]
11. Autologous olfactory ensheathing cell transplantation in human spinal cord injury.
Féron F; Perry C; Cochrane J; Licina P; Nowitzke A; Urquhart S; Geraghty T; Mackay-Sim A
Brain; 2005 Dec; 128(Pt 12):2951-60. PubMed ID: 16219671
[TBL] [Abstract][Full Text] [Related]
12. Transplantation of autologous bone marrow mesenchymal stem cells in the treatment of complete and chronic cervical spinal cord injury.
Dai G; Liu X; Zhang Z; Yang Z; Dai Y; Xu R
Brain Res; 2013 Oct; 1533():73-9. PubMed ID: 23948102
[TBL] [Abstract][Full Text] [Related]
13. Functional regeneration of supraspinal connections in a patient with transected spinal cord following transplantation of bulbar olfactory ensheathing cells with peripheral nerve bridging.
Tabakow P; Raisman G; Fortuna W; Czyz M; Huber J; Li D; Szewczyk P; Okurowski S; Miedzybrodzki R; Czapiga B; Salomon B; Halon A; Li Y; Lipiec J; Kulczyk A; Jarmundowicz W
Cell Transplant; 2014; 23(12):1631-55. PubMed ID: 25338642
[TBL] [Abstract][Full Text] [Related]
14. Image-guided percutaneous intralesional administration of mesenchymal stromal cells in subjects with chronic complete spinal cord injury: a pilot study.
Larocca TF; Macêdo CT; Souza BSF; Andrade-Souza YM; Villarreal CF; Matos AC; Silva DN; da Silva KN; de Souza CLEM; Paixão DDS; Bezerra MDR; Alves RL; Soares MBP; Dos Santos RR
Cytotherapy; 2017 Oct; 19(10):1189-1196. PubMed ID: 28760352
[TBL] [Abstract][Full Text] [Related]
15. Omental transposition in chronic spinal cord injury.
Clifton GL; Donovan WH; Dimitrijevic MM; Allen SJ; Ku A; Potts JR; Moody FG; Boake C; Sherwood AM; Edwards JV
Spinal Cord; 1996 Apr; 34(4):193-203. PubMed ID: 8963963
[TBL] [Abstract][Full Text] [Related]
16. Continuous improvement after multiple mesenchymal stem cell transplantations in a patient with complete spinal cord injury.
Jarocha D; Milczarek O; Wedrychowicz A; Kwiatkowski S; Majka M
Cell Transplant; 2015; 24(4):661-72. PubMed ID: 25807231
[TBL] [Abstract][Full Text] [Related]
17. Multicenter prospective nonrandomized controlled clinical trial to prove neurotherapeutic effects of granulocyte colony-stimulating factor for acute spinal cord injury: analyses of follow-up cases after at least 1 year.
Inada T; Takahashi H; Yamazaki M; Okawa A; Sakuma T; Kato K; Hashimoto M; Hayashi K; Furuya T; Fujiyoshi T; Kawabe J; Mannoji C; Miyashita T; Kadota R; Someya Y; Ikeda O; Hashimoto M; Suda K; Kajino T; Ueda H; Ito Y; Ueta T; Hanaoka H; Takahashi K; Koda M
Spine (Phila Pa 1976); 2014 Feb; 39(3):213-9. PubMed ID: 24299727
[TBL] [Abstract][Full Text] [Related]
18. Treatment of complete spinal cord injury patients by autologous bone marrow cell transplantation and administration of granulocyte-macrophage colony stimulating factor.
Park HC; Shim YS; Ha Y; Yoon SH; Park SR; Choi BH; Park HS
Tissue Eng; 2005; 11(5-6):913-22. PubMed ID: 15998231
[TBL] [Abstract][Full Text] [Related]
19. Co-transplantation of autologous bone marrow mesenchymal stem cells and Schwann cells through cerebral spinal fluid for the treatment of patients with chronic spinal cord injury: safety and possible outcome.
Oraee-Yazdani S; Hafizi M; Atashi A; Ashrafi F; Seddighi AS; Hashemi SM; Seddighi A; Soleimani M; Zali A
Spinal Cord; 2016 Feb; 54(2):102-9. PubMed ID: 26526896
[TBL] [Abstract][Full Text] [Related]
20. Treatment of chronic thoracic spinal cord injury patients with autologous Schwann cell transplantation: an interim report on safety considerations and possible outcomes.
Saberi H; Moshayedi P; Aghayan HR; Arjmand B; Hosseini SK; Emami-Razavi SH; Rahimi-Movaghar V; Raza M; Firouzi M
Neurosci Lett; 2008 Sep; 443(1):46-50. PubMed ID: 18662744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
